Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Prognosis
4958 results:

  • 1. The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
    Chen H; Wang C; Chen Z; Huang T; Lin Y; Chen J; Zhang B; He X
    BMC Cancer; 2024 Apr; 24(1):433. PubMed ID: 38589842
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study.
    Matsubara D; Soga K; Ikeda J; Kumano T; Mitsuda M; Konishi T; Komatsu S; Shimomura K; Taniguchi F; Shioaki Y; Otsuji E
    BMC Gastroenterol; 2024 Apr; 24(1):125. PubMed ID: 38566007
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
    Lee KH; Yang IJ; Ha GW; Lee J; Park YY; Lee SH; Lee JM; Bae JH; Park EJ; Kim H; Kim KY; An S; Kim IY; Kim JY
    BMC Cancer; 2024 Mar; 24(1):397. PubMed ID: 38553680
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis.
    Wang Y; Cao Y; Chen Y; Cheng H; Liu Z; Wang M; Feng Y; Fei B; Cui K; Huang Z
    Med Oncol; 2024 Mar; 41(5):100. PubMed ID: 38538804
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High-risk Patients With colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. colorectal cancer Patients' Reported Frequency, Content, and Satisfaction with Advance Care Planning Discussions.
    Hussein S; Lim CA; Manokaran T; Kassam S; Earp M; Tang PA; Karim S; Biondo P; Watanabe SM; Sinnarajah A; Tan A; Simon J
    Curr Oncol; 2024 Feb; 31(3):1235-1245. PubMed ID: 38534925
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extranodal Extension at Pretreatment MRI and the Prognostic Value for Patients with Rectal cancer.
    Li QY; Yang D; Guan Z; Yan XY; Li XT; Sun RJ; Lu QY; Zhang XY; Sun YS
    Radiology; 2024 Mar; 310(3):e232605. PubMed ID: 38530176
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
    Zhou YW; Zhao X; Ni L; Cao P; Leng WB; Zhu Q; Gou HF; Zhang J; Li XF; Qiu M
    Int Immunopharmacol; 2024 Apr; 131():111887. PubMed ID: 38503018
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
    Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
    Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Martín-Cullell B; Virgili AC; Riera P; Fumagalli C; Mirallas O; Pelegrín FJ; Sánchez-Cabús S; Molina V; Szafranska J; Páez D
    Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38488528
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.
    Jing ZL; Liu GL; Zhou N; Xu DY; Feng N; Lei Y; Ma LL; Tang MS; Tong GH; Tang N; Deng YJ
    Sci Rep; 2024 Mar; 14(1):6053. PubMed ID: 38480774
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis.
    Jun SY; Cho S; Kim MJ; Park JW; Ryoo SB; Jeong SY; Park KJ; Shin A
    Cancer Med; 2024 Mar; 13(5):e7084. PubMed ID: 38477501
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]    [Full Text] [Related]  

  • 17. Crosstalk of cell death pathways unveils an autophagy-related gene AOC3 as a critical prognostic marker in colorectal cancer.
    Xu H; Cui H; Weng S; Zhang Y; Wang L; Xing Z; Han X; Liu Z
    Commun Biol; 2024 Mar; 7(1):296. PubMed ID: 38461356
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Ascending Colon cancer with Radical Resection after Stent Reimplantation Due to Colonic Stent Obstruction for Palliation-A Case Report].
    Hanaoka K; Ichikawa Y; Miyake M; Sakurai T; Inoue T; Matsumoto K; Furukawa H; Higashi S; Tsunashima R; Morishima H; Kashiwazaki M; Tanemura M
    Gan To Kagaku Ryoho; 2024 Feb; 51(2):208-210. PubMed ID: 38449415
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A New Automated Prognostic Prediction Method Based on Multi-Sequence Magnetic Resonance Imaging for Hepatic Resection of colorectal cancer Liver Metastases.
    Tang L; Zhang Z; Yang J; Feng Y; Sun S; Liu B; Ma J; Liu J; Shao H
    IEEE J Biomed Health Inform; 2024 Mar; 28(3):1528-1539. PubMed ID: 38446655
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
    Duan J; Zhu L; Shi Y; Wang W; Wang T; Ning T; Zhang L; Bai M; Li H; Liu R; Ge S; Wang X; Yang Y; Ji Z; Wang F; Sun Y; Ba Y; Deng T
    BMC Cancer; 2024 Mar; 24(1):302. PubMed ID: 38443891
    [TBL] [Abstract] [Full Text] [Related]  


    of 248.